サンプル依頼リスト カート
  • English
  • Korean
表紙：止血診断の世界市場規模調査＆予測：製品別、検査タイプ別、最終用途別、地域別分析、2023-2030年
市場調査レポート
商品コード
1315029

止血診断の世界市場規模調査＆予測：製品別、検査タイプ別、最終用途別、地域別分析、2023-2030年

Global Hemostasis Diagnostics Market Size study & Forecast, by Product, by Test Type, by End Use and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
止血診断の世界市場規模調査＆予測：製品別、検査タイプ別、最終用途別、地域別分析、2023-2030年
出版日: 2023年07月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の止血診断市場は、2022年に約641万米ドルと評価され、予測期間2023-2030年には8.60%以上の健全な成長率で成長すると予測されています。

止血診断装置は、過剰な出血を引き起こす止血障害の発見に役立ちます。止血中、血液は液体からゲル状に変化します。止血は、傷害後に身体が出血を制限して血流を止めるために用いる技術です。血管収縮、血小板の栓形成、血液凝固です。患者、特に処置後に体から余分な血液を失いやすい患者における血液凝固診断率の上昇は、市場拡大を促進する重要な理由です。がん、糖尿病、神経疾患など多くの疾患の罹患率の増加、高齢者人口の増加、ライフスタイルの変化が止血診断市場を牽引しています。予測期間中、世界の止血診断市場は血友病有病率の増加によって牽引されると予想されます。

血液凝固障害の発生件数の増加、医療における技術開発、自動止血装置の受け入れ拡大などが、検討中の市場の成長に影響を与えています。World Bleeding Disorders Registry 2021報告書によると、37カ国の調査で2021年12月時点で血友病患者は9,414人と報告されており、罹患者数では東南アジアが2,828人と最も多く、次いで東地中海が2,418人、アフリカが1,027人となっています。さらに、分子診断検査や専門的診断検査を小型化するための研究開発の継続的な進展は、予測期間中に市場に有利な機会を創出すると予想されます。しかし、新興国市場では、厳しい政府規制に加えて、止血疾患に対する認識不足が、2023-2030年の予測期間を通じて市場成長の妨げになる可能性があります。

止血診断の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、強力な自動分析装置の普及、大規模な患者プールの利用可能性、血栓症の頻度の高さ、政府の支持的な取り組みにより、2022年の市場を独占しました。アジア太平洋地域は予測期間中に大きく成長すると予想され、この地域の市場急拡大は、医療インフラの改善を目的としたいくつかの政府の取り組みに起因しています。同地域の市場は他の地域と比較して大きく成長すると予想されるが、これは製薬ビジネスや臨床研究産業の基盤が先進国から中国やインドなどの新興国へと変化しているためです。

本調査の目的は、近年における様々なセグメント・国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界および部門別の市場予測と予測、2020～2030年
    • 止血診断市場、地域別、2020～2030年
    • 止血診断市場、製品別、2020～2030年
    • 止血診断市場、検査タイプ別、2020～2030年
    • 止血診断市場、最終用途別、2020～2030年
  • 主要な動向
  • 推定調査手法
  • 調査前提条件

第2章 世界の止血診断市場の定義と範囲

  • 研究の目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 研究の対象となった年数
  • 通貨換算レート

第3章 世界の止血診断市場力学

  • 止血診断市場への影響分析（2020年から2030年）
    • 市場促進要因
      • 血液凝固障害の発生率の増加
      • 自動止血装置の導入が増加
    • 市場の課題
      • 厳しい政府規制
    • 市場機会
      • 研究開発の進歩

第4章 世界の止血診断市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済的
    • 社交
    • 技術的
    • 環境
    • 法的
  • 主な投資機会
  • 主要成功戦略
  • COVID-19感染症の影響分析
  • 破壊的な動向
  • 業界専門家の視点
  • アナリストの推奨事項と結論

第5章 世界の止血診断市場、製品別

  • 市場スナップショット
  • 世界の止血診断市場：製品別、実績- ポテンシャル分析
  • 世界の止血診断市場：製品別、推定と予測2020年～2030年
  • 止血診断市場、サブセグメント分析
    • 臨床検査用分析装置
    • ポイントオブケア検査システム

第6章 世界の止血診断市場、検査タイプ別

  • 市場スナップショット
  • 世界の止血診断市場：検査タイプ別、実績- ポテンシャル分析
  • 世界の止血診断市場：検査タイプ別、推定と予測2020～2030年
  • 止血診断市場、サブセグメント分析
    • 活性化された部分トロンボプラスチン時間
    • Dダイマーテスト
    • フィブリノゲン検査
    • プロトロンビン時間検査
    • 活性化凝固時間
    • 血小板凝集検査

第7章 世界の止血診断市場、最終用途別

  • 市場スナップショット
  • 世界の止血診断市場：最終用途別、実績- ポテンシャル分析
  • 世界の止血診断市場：最終用途別、推定と予測2020～2030年
  • 止血診断市場、サブセグメント分析
    • 病院
    • 診断センター
    • その他

第8章 世界の止血診断市場、地域分析

  • 主要国
  • 主な新興国
  • 止血診断市場、地域市場スナップショット
  • 北米
    • 米国
      • 製品の内訳の見積もりと予測、2020～2030年
      • テストタイプの内訳の見積もりと予測、2020～2030年
      • 最終用途の内訳の見積もりと予測、2020～2030年
    • カナダ
  • 欧州の止血診断市場のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の止血診断市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの止血診断市場のスナップショット
    • ブラジル
    • メキシコ
  • 中東とアフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Abbott
      • 重要な情報
      • 概要
      • 財務（データの入手可能性による）
      • 製品概要
      • 最近の動向
    • Thermo Fisher Scientific Inc.
    • HORIBA Europe Holding
    • Medtronic
    • Technidyne Corporation
    • Grifols SA
    • F. Hoffmann-La Roche Ltd.
    • NIHON KOHDEN CORPORATION
    • Haemonetics Corporation
    • Beckman Coulter Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査の属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Hemostasis Diagnostics Market, report scope
  • TABLE 2. Global Hemostasis Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Hemostasis Diagnostics Market estimates & forecasts by Product 2020-2030 (USD Million)
  • TABLE 4. Global Hemostasis Diagnostics Market estimates & forecasts by Test Type 2020-2030 (USD Million)
  • TABLE 5. Global Hemostasis Diagnostics Market estimates & forecasts by End Use 2020-2030 (USD Million)
  • TABLE 6. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17. U.S. Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. U.S. Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19. Canada Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20. Canada Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. Canada Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22. UK Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23. UK Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. UK Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25. Germany Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26. Germany Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. Germany Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28. France Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29. France Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. France Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31. Italy Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32. Italy Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Italy Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34. Spain Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35. Spain Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. Spain Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37. RoE Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38. RoE Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. RoE Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40. China Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41. China Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. China Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43. India Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44. India Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. India Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46. Japan Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47. Japan Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. Japan Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49. South Korea Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50. South Korea Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. South Korea Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52. Australia Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53. Australia Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. Australia Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. RoAPAC Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58. Brazil Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59. Brazil Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Brazil Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61. Mexico Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62. Mexico Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. Mexico Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64. RoLA Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65. RoLA Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. RoLA Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67. Saudi Arabia Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68. South Africa Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. RoMEA Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Hemostasis Diagnostics Market
  • TABLE 71. List of primary sources, used in the study of global Hemostasis Diagnostics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Hemostasis Diagnostics Market, research methodology
  • FIG 2. Global Hemostasis Diagnostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Hemostasis Diagnostics Market, key trends 2022
  • FIG 5. Global Hemostasis Diagnostics Market, growth prospects 2023-2030
  • FIG 6. Global Hemostasis Diagnostics Market, porters 5 force model
  • FIG 7. Global Hemostasis Diagnostics Market, pest analysis
  • FIG 8. Global Hemostasis Diagnostics Market, value chain analysis
  • FIG 9. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Hemostasis Diagnostics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Hemostasis Diagnostics Market 2020 & 2030 (USD Million)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Hemostasis Diagnostics Market is valued approximately USD 6.41 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2023-2030. Hemostasis diagnostic devices help discover hemostatic disorders that cause excessive bleeding. During hemostasis, blood transforms from liquid to gelatinous. Hemostasis is a technique that the body uses after an injury to limit blood loss and cease blood flow. Following this, there are three further steps: vasoconstriction, platelet plug formation, and blood coagulation. Rising blood clotting diagnostic rates among patients, particularly those who are more prone to losing extra blood from the body after procedures, are important reasons driving market expansion. The growth in the incidence of many diseases such as cancer, diabetes, and neurological disorders, as well as the increase in the older population and lifestyle changes, drive the hemostasis diagnostics market. During the projected period, the worldwide hemostasis diagnostics market is expected to be driven by an increase in the prevalence of haemophilia.

Rising incidents of blood clotting disorders, technical developments in medical treatment, and increased acceptance of automated hemostasis equipment are all having an impact on the growth of the market under consideration. According to the World Bleeding Disorders Registry 2021 report, a survey of 37 countries reported 9,414 people with haemophilia as of December 2021, with South-East Asia having the highest prevalence with 2,828 affected individuals, followed by the Eastern Mediterranean and Africa with 2,418 and 1,027 affected individuals, respectively. Additionally, growing continuous advancement in research and development initiatives to miniaturize molecular and professional diagnostic testing is anticipated to create the lucrative opportunity for the market during forecast period. However, a lack of awareness about hemostasis diseases in developing regions, in addition to stringent government regulations, might hinder the market growth throughout the forecast period of 2023-2030

The key regions considered for the Global Hemostasis Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the widespread use of powerful automated analyzers, the availability of a large patient pool, and the high frequency of blood clot illnesses, and supportive government initiatives. Asia Pacific is expected to grow significantly during the forecast period, the region's rapid market rise can be ascribed to several government efforts aimed at improving health-care infrastructure. The market in the area is expected to grow significantly in comparison to other regions, owing to a change in the base of pharmaceutical businesses and clinical research industries from developed to emerging nations such as China and India.

Major market player included in this report are:

  • Abbott
  • Thermo Fisher Scientific Inc.
  • HORIBA Europe Holding
  • Medtronic
  • Technidyne Corporation
  • Grifols S.A
  • F. Hoffmann-La Roche Ltd.
  • NIHON KOHDEN CORPORATION
  • Haemonetics Corporation
  • Beckman Coulter Inc.

Recent Developments in the Market:

  • In December 2022, the US FDA granted HemoSonics' Quantra Hemostasis System with QStat Cartridge 510(k) commercial approval The QStat Cartridge test, according to the manufacturer, expands Quantra's total diagnostic capabilities. The newest point-of-care hemostasis analyzer in the United States, the next-generation whole-blood hemostasis system, covers the broadest range of clinical purposes.
  • In November 2022, a Dutch company, Enzyre, which is developing ambulant diagnostic technology for blood coagulation testing, successfully raised USD 11.9 million (EUR 12 million) in series A funding to help hemophilia patients test from home

Global Hemostasis Diagnostics Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimatio: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Test Type, End Use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Laboratory Analyzers
  • Point-of-Care Testing Systems

By Test Type:

  • Activated Partial Thromboplastin Time
  • D Dimer Test
  • Fibrinogen Test
  • Prothrombin Time Test
  • Activated Clotting Time
  • Platelet Aggregation Test

By End Use:

  • Hospitals
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Hemostasis Diagnostics Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Hemostasis Diagnostics Market, by Product, 2020-2030 (USD Million)
    • 1.2.3. Hemostasis Diagnostics Market, by Test Type, 2020-2030 (USD Million)
    • 1.2.4. Hemostasis Diagnostics Market, by End Use, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Hemostasis Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Hemostasis Diagnostics Market Dynamics

  • 3.1. Hemostasis Diagnostics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Incidences of Blood Clotting Disorders
      • 3.1.1.2. Rising Adoption of Automated Hemostasis Equipment
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent Government Regulation
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in R&D

Chapter 4. Global Hemostasis Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Hemostasis Diagnostics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Hemostasis Diagnostics Market by Product, Performance - Potential Analysis
  • 5.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Hemostasis Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Laboratory Analyzers
    • 5.4.2. Point-of-Care Testing Systems

Chapter 6. Global Hemostasis Diagnostics Market, by Test Type

  • 6.1. Market Snapshot
  • 6.2. Global Hemostasis Diagnostics Market by Test Type, Performance - Potential Analysis
  • 6.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Test Type 2020-2030 (USD Million)
  • 6.4. Hemostasis Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Activated Partial Thromboplastin Time
    • 6.4.2. D Dimer Test
    • 6.4.3. Fibrinogen Test
    • 6.4.4. Prothrombin Time Test
    • 6.4.5. Activated Clotting Time
    • 6.4.6. Platelet Aggregation Test

Chapter 7. Global Hemostasis Diagnostics Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Hemostasis Diagnostics Market by End Use, Performance - Potential Analysis
  • 7.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
  • 7.4. Hemostasis Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Diagnostic Centers
    • 7.4.3. Others

Chapter 8. Global Hemostasis Diagnostics Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Hemostasis Diagnostics Market, Regional Market Snapshot
  • 8.4. North America Hemostasis Diagnostics Market
    • 8.4.1. U.S. Hemostasis Diagnostics Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Test Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Hemostasis Diagnostics Market
  • 8.5. Europe Hemostasis Diagnostics Market Snapshot
    • 8.5.1. U.K. Hemostasis Diagnostics Market
    • 8.5.2. Germany Hemostasis Diagnostics Market
    • 8.5.3. France Hemostasis Diagnostics Market
    • 8.5.4. Spain Hemostasis Diagnostics Market
    • 8.5.5. Italy Hemostasis Diagnostics Market
    • 8.5.6. Rest of Europe Hemostasis Diagnostics Market
  • 8.6. Asia-Pacific Hemostasis Diagnostics Market Snapshot
    • 8.6.1. China Hemostasis Diagnostics Market
    • 8.6.2. India Hemostasis Diagnostics Market
    • 8.6.3. Japan Hemostasis Diagnostics Market
    • 8.6.4. Australia Hemostasis Diagnostics Market
    • 8.6.5. South Korea Hemostasis Diagnostics Market
    • 8.6.6. Rest of Asia Pacific Hemostasis Diagnostics Market
  • 8.7. Latin America Hemostasis Diagnostics Market Snapshot
    • 8.7.1. Brazil Hemostasis Diagnostics Market
    • 8.7.2. Mexico Hemostasis Diagnostics Market
  • 8.8. Middle East & Africa Hemostasis Diagnostics Market
    • 8.8.1. Saudi Arabia Hemostasis Diagnostics Market
    • 8.8.2. South Africa Hemostasis Diagnostics Market
    • 8.8.3. Rest of Middle East & Africa Hemostasis Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Abbott
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Thermo Fisher Scientific Inc.
    • 9.3.3. HORIBA Europe Holding
    • 9.3.4. Medtronic
    • 9.3.5. Technidyne Corporation
    • 9.3.6. Grifols S.A
    • 9.3.7. F. Hoffmann-La Roche Ltd.
    • 9.3.8. NIHON KOHDEN CORPORATION
    • 9.3.9. Haemonetics Corporation
    • 9.3.10. Beckman Coulter Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption